Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 160

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 160
---
controlling interest

    103

    54

    177

    Net loss attributable to Adaptive Biotechnologies Corporation
     
    $
    (159,492
    )
     
    $
    (225,250
    )
     
    $
    (200,191
    )

    Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted
     
    $
    (1.08
    )
     
    $
    (1.56
    )
     
    $
    (1.40
    )

    Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted

    147,101,648

    144,383,294

    142,515,917

The accompanying notes are an integral part of these consolidated financial statements.

92

Adaptive Biotechnologies Corporation

Consolidated Statements of Comprehensive Loss

(in thousands)

    Year Ended December 31,

    2024

    2023

    2022

    Net loss
     
    $
    (159,595
    )
     
    $
    (225,304
    )
     
    $
    (200,368
    )

    Other comprehensive (loss) income

    Change in unrealized gains and losses on investments

    (49
    )

    4,331

    (2,979
    )

    Comprehensive loss

    (159,644
    )

    (220,973
    )

    (203,347
    )

    Add: Comprehensive loss attributable to noncontrolling interest

    103

    54

    177

    Comprehensive loss attributable to Adaptive Biotechnologies Corporation
     
    $
    (159,541
    )
     
    $
    (220,919
    )
     
    $
    (203,170
    )

The accompanying notes are an integral part of these consolidated financial statements.

93

Adaptive Biotechnologies Corporation

Consolidated Statements of Shareholders’ Equity

(in thousands, except share amounts)

    Common Stock

    AdditionalPaid-In

    AccumulatedOtherComprehensive

    Accumulated

    Noncontrolling

    TotalShareholders’

    Shares

    Amount

    Capital

    (Loss) Gain

    Deficit

    Interest

    Equity

    Balance at December 31, 2021

    141,393,